TY  - GEN
AU  - Yamamura,Kazuo
AU  - Kasuya,Hideki
AU  - Sahin,Tevfik Tolga
AU  - Tan,Gewen
AU  - Hotta,Yoshihiro
AU  - Tsurumaru,Naoko
AU  - Fukuda,Saori
AU  - Kanda,Mitsuro
AU  - Kobayashi,Daisuke
AU  - Tanaka,Chie
AU  - Yamada,Suguru
AU  - Nakayama,Goro
AU  - Fujii,Tsutomu
AU  - Sugimoto,Hiroyuki
AU  - Koike,Masahiko
AU  - Nomoto,Shuji
AU  - Fujiwara,Michitaka
AU  - Tanaka,Maki
AU  - Kodera,Yasuhiro
TI  - Combination treatment of human pancreatic cancer xenograft models with the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib and oncolytic herpes simplex virus HF10
SN  - 1534-4681
PY  - 2014///1030
KW  - Animals
KW  - Apoptosis
KW  - Cell Proliferation
KW  - Combined Modality Therapy
KW  - Disease Models, Animal
KW  - ErbB Receptors
KW  - antagonists & inhibitors
KW  - Erlotinib Hydrochloride
KW  - Humans
KW  - Immunoenzyme Techniques
KW  - Male
KW  - Mice
KW  - Mice, Inbred BALB C
KW  - Mice, Nude
KW  - Neovascularization, Pathologic
KW  - prevention & control
KW  - Oncolytic Virotherapy
KW  - Pancreatic Neoplasms
KW  - genetics
KW  - Protein Kinase Inhibitors
KW  - therapeutic use
KW  - Quinazolines
KW  - Simplexvirus
KW  - physiology
KW  - Survival Rate
KW  - Tumor Cells, Cultured
KW  - Virus Internalization
KW  - Virus Replication
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1245/s10434-013-3329-3
ER  -